MDNA — Medicenna Therapeutics Corp.

MDNAMedicenna Therapeutics Corp.

TSX · CA · Healthcare · Biotechnology · medicenna.com

0.4300CAD+1.18%Mkt Cap: 35.87M CADP/E: —Last update: 2026-06-01

Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap35.87M CAD

Enterprise Value24.97M CAD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-11.80M CAD

Revenue/Share—

Last Price0.4300 CAD

Fiscal Year EndMar 2025

MR QuarterDec 2025

Employees18

CountryCA

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.85

PEG—

EV/EBITDA-1.12

EV/Revenue—

P/S—

P/B5.74

EPS (TTM)-0.15

EPS (Forward)-0.23

52W Range

0.41801% of range1.970

52W High1.970 CAD

52W Low0.4180 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-61.82%

ROA-41.59%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-16.49M CAD

CapEx (TTM)33.00K CAD

FCF Margin—

FCF Yield-30.23%

Net Debt-10.48M CAD

Net Debt/EBITDA0.47

Balance Sheet

Debt/Equity0.01

Current Ratio2.68

Quick Ratio2.50

Book Value/Sh0.0740 CAD

Cash/Share0.1270 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMar 3, 2017

Analyst Consensus

Rating—

Target (Mean)3.875 CAD

Target Range3.750 CAD – 4.000 CAD

# Analysts2

Ownership

Shares Out.83.42M

Float65.95M

Insiders21.00%

Institutions0.00%

Short Interest

Short Ratio1.8d

Short % Float0.84%

Short % Out.0.30%

Shares Short247.52K

Short (prev mo.)104.13K

Technical

SMA 500.5891 (-27.0%)

SMA 2000.9535 (-54.9%)

Beta1.91

S&P 52W Chg27.70%

Avg Vol (30d)127.39K

Avg Vol (10d)134.62K

Technical Indicators

RSI (14)33.2

MACD-0.0544

MACD Signal-0.0450

MACD Hist.-0.0094

BB Upper0.7167 CAD

BB Middle0.5363 CAD

BB Lower0.3558 CAD

BB Width67.32%

ATR (14)0.0467 CAD

Vol Ratio (20d)0.32x